[对萨尔布塔摩尔/伊普拉的使用提出无根据的反对意见]
Eliane A Lucassen1,2, Ragna Rood3, Jeroen Tibboel4
1Haga Ziekenhuis, afd. Interne Geneeskunde, Den Haag.
Nederlands tijdschrift voor geneeskunde
|July 17, 2025
概括
伊普拉和萨尔布塔摩尔的组合可为喘和COPD恶化提供优质的支气管扩张. 关于沙尔布他的心脏安全问题在很大程度上是毫无根据的,即使在心脏病患者中也是如此.
科学领域:
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘/COPD恶化中的急性支气管,通常涉及到ipratropium (抗胆固醇) 和沙布塔摩尔 (β2-agonist).
- 与单独的伊普拉相比,组合疗法提供了增强的支气管扩张.
- 人们对沙尔布他的心脏安全概况存在担忧.
研究的目的:
- 评估沙尔布他的心脏安全性,特别是当它与急性支气管的伊普拉联合使用时.
- 为了解决在患有心动减速或心脏病的患者中使用伊普拉/萨尔布塔摩尔的不合理谨慎问题.
主要方法:
- 对萨尔布塔摩尔在不同患者群体 (ED,ICU,儿童) 的心脏影响现有文献的综述.
- 分析心率,QTc间隔和QTc分散的变化与标准和高剂量沙布塔摩尔.
- 在接受沙布塔摩尔治疗的患者与安慰剂治疗中的心律失常发病率的评估.
主要成果:
- 标准萨尔布塔摩尔剂量在不同患者群体中不会显著影响心率.
- 高剂量萨尔布塔摩尔 (5-10倍标准) 会导致心率和QTc间隔的轻微增加,而不是临床上相关的.
- 文献表明,萨尔布塔摩尔和安慰剂之间的心律失常发生率相似,没有观察到严重的心律失常.
结论:
- 萨尔布塔摩尔的心脏安全性已经得到充分证实,即使是在心脏并发症或严重COPD的患者中也是如此.
- 目前关于ipratropium/salbutamol联合治疗的临床谨慎是不合理的.
- 由于先前存在的心动减速或心脏病,不应暂停用伊普拉/萨尔布塔摩尔治疗.
相关概念视频
Antiasthma Drugs: Muscarinic Receptor Antagonists
465
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
465
Antiasthma Drugs: β2-Adrenoceptor Agonists
392
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
392
Inhaled Medications
396
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
396
Cholinergic Antagonists: Pharmacokinetics
564
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
564
Cholinergic Antagonists: Therapeutic Uses
880
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
880
Antiasthma Drugs: Methylxanthines
412
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
412


